NCT04734197: A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease |
|
|
| Completed | 2 | 351 | US | SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), Mycophenolic Acid 0.1%, Mycophenolic Acid 0.3%, Betamethasone Sodium Phosphate 0.01%, Placebo Comparator: Vehicle, Cyclosporine 0.05% Ophthalmic Emulsion, Restasis 0.05% ophthalmic emulsion, Lifitegrast 5% Ophthalmic Solution, Xiidra 5% Ophthalmic Solution | Surface Pharmaceuticals, Inc. | Dry Eye Disease | 03/22 | 03/22 | | |
